agilon health Reports Q3 2026 Profitability and Raises Full Year Guidance
agilon health (AGL) reported a significant financial turnaround in the third quarter of 2026, posting a net income of $35 million compared to a $110 million loss in the same period last year. Despite a 10% decline in Medicare Advantage membership due to strategic market exits and a focus on profitability, total revenue grew 6% to $1.52 billion, bolstered by favorable risk adjustment and benchmark rates. The company's performance led management to raise its full-year 2026 Adjusted EBITDA guidance significantly to a range of $145 million to $155 million, up from the previous estimate of $75 million to $95 million. Additionally, revenue guidance was revised upward to between $5.87 billion and $5.89 billion. These improvements reflect successful cost management within the Accountable Care Organization (ACO) segment and a notable decrease in the Medical Services Expense Ratio.
Tickers: $AGL
Topics: EBITDA beat guidance revision membership decline net income turnaround revenue growth